Ann Haight MD

Department of Pediatrics
Associate Professor

Aflac Cancer and Blood Disorders Center
Pediatrics
2015 Uppergate Drive

Academic Appointment

Associate Professor of Pediatrics, School of Medicine, Emory University

Education

Degrees

MD from Medical College of Georgia
BS from Biology Rhodes College

Research

Focus

My clinical research interests lie in blood and marrow transplantation for sickle cell anemia, supportive care in BMT, and bioethics. Through active participation in consortia-based multicenter trials and as an IRB leader, I am committed to the success of well designed, well executed collaborative trials improving clinical outcomes for children.

Publications

Feasibility of a Yoga Intervention for Children and Adolescents Undergoing Hematopoietic Cell Transplant.
Phys Occup Ther Pediatr Page(s): 1 - 16
04/24/2025 Authors: Easley T; Haight A; Hall T; Palmer K; Konter J; Hayes R; Nelson JL; Cherven B
Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.
Am J Hematol Volume: 99 Page(s): 2037 - 2040
10/01/2024 Authors: Arnold SD; Bakshi N; Ross D; Smith C; Sinha C; Veludhandi A; Dutreuil V; Bai S; Meacham LR; Guilcher G
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Am J Hematol Volume: 99 Page(s): 785 - 788
04/01/2024 Authors: Eapen M; Kou J; Andreansky M; Bhatia M; Brochstein J; Chaudhury S; Haight AE; Haines H; Jacobsohn D; Jaroscak J
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
Transplant Cell Ther Volume: 29 Page(s): 531.e1 - 531.e4
08/01/2023 Authors: Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L
IMPACT OF TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY AND ACUTE GRAFT VERSUS HOST DISEASE ON SURVIVAL IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC CELLULAR TRANSPLANTATION
Volume: 70 Page(s): S217 - S217
06/01/2023 Authors: Schoettler M; Harris A; Bryson E; Deeb L; Watkins B; Haight A; Parikh S; Chandrakasan S; Stenger E; Liang W
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
Blood Adv Volume: 7 Page(s): 2196 - 2205
05/23/2023 Authors: Stenger EO; Watkins B; Rogowski K; Chiang K-Y; Haight A; Leung K; Qayed M; Raghunandan S; Suessmuth Y; Kean L
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
Blood Adv Volume: 7 Page(s): 1784 - 1795
05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
Comparison of Anti-Mullerian Hormone Levels Pre- and Post-Hematopoietic Cell Transplantation in Pediatric and Adolescent Females with Sickle Cell Disease.
Transplant Cell Ther Volume: 28 Page(s): 770.e1 - 770.e6
11/01/2022 Authors: George SA; Lai KW; Lewis RW; Bryson EW; Haight AE; Meacham LR
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.
JMIR Res Protoc Volume: 11 Page(s): e36780
07/06/2022 Authors: Krishnamurti L; Arnold SD; Haight A; Abraham A; Guilcher GM; John T; Bakshi N; Shenoy S; Syrjala K; Martin PL
REVACCINATION ADHERENCE FOR PEDIATRIC PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
Volume: 69
06/01/2022 Authors: Yarnall JN; Khemani K; Haight A; Goggin K
REDUCING DURATION OF EMPIRIC ANTIBIOTICS IN CHILDREN UNDERGOING STEM CELL TRANSPLANTATION
Volume: 69
06/01/2022 Authors: Patel P; Teherani M; Xiang Y; Bernardo V; Chandrakasan S; Goggin K; Haight A; Horwitz E; Liang W; Parikh S
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
Transplant Cell Ther Volume: 28 Page(s): 329.e1 - 329.e9
06/01/2022 Authors: Rangarajan HG; Stanek JR; Abdel-Azim H; Modi A; Haight A; McKinney CM; McKeone DJ; Buchbinder DK; Katsanis E; Abusin GA
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.
Transplant Cell Ther Volume: 27 Page(s): 352.e1 - 352.e5
04/01/2021 Authors: Seftel MD; Chitphakdithai P; Miller JP; Kobusingye H; Logan BR; Linenberger M; Artz AS; Haight AE; Jacobsohn DA; Litzow MR
Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.
Volume: 42 Page(s): e575 - e582
10/01/2020 Authors: Elchuri SV; Williamson Lewis R; Quarmyne M-O; Haight AE; Cottrell HN; Meacham LR
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
Br J Haematol Volume: 189 Page(s): 162 - 170
04/01/2020 Authors: Nickel RS; Horan JT; Abraham A; Qayed M; Haight A; Ngwube A; Liang H; Luban NLC; Hendrickson JE
Abatacept for Gvhd Prophylaxis after Hematopoietic Cell Transplantation (HCT) for Pediatric Sickle Cell Disease (SCD): A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Trial
Volume: 26 Page(s): S20 - S20
03/01/2020 Authors: Chaudhury S; Volonte B; Rangarajan HG; Horan J; Haight AE; Abraham A; Ngwube A; Krajewski J; Guilcher GMT; Bhatia M
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
Biol Blood Marrow Transplant Volume: 25 Page(s): 955 - 964
05/01/2019 Authors: Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman SF; Varni JW; Kobusingye H
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica Volume: 104 Page(s): 844 - 854
04/01/2019 Authors: Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant Volume: 25 Page(s): 699 - 711
04/01/2019 Authors: Pulsipher MA; Logan BR; Chitphakdithai P; Kiefer DM; Riches ML; Rizzo JD; Anderlini P; Leitman SF; Varni JW; Kobusingye H
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Am J Hematol Volume: 94 Page(s): 446 - 454
04/01/2019 Authors: Krishnamurti L; Neuberg DS; Sullivan KM; Kamani NR; Abraham A; Campigotto F; Zhang W; Dahdoul T; De Castro L; Parikh S
Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA-matched siblings with primary immunodeficiency.
Pediatr Blood Cancer Volume: 66 Page(s): e27602
04/01/2019 Authors: Parikh SH; Pentz RD; Haight A; Adeli M; Martin PL; Driscoll TA; Page K; Kurtzberg J; Prasad VK; Barfield RC
Necrotizing fasciitis caused by Mucor indicus in a pediatric bone marrow transplant recipient.
Pediatr Transplant Volume: 22 Page(s): e13294
12/01/2018 Authors: Bloch D; Gonzalez MD; Haight A; Abramowsky C; Yildirim I
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Blood Volume: 132 Page(s): 1737 - 1749
10/25/2018 Authors: Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.
Biol Blood Marrow Transplant Volume: 24 Page(s): 2040 - 2046
10/01/2018 Authors: Jacobsohn DA; Loken MR; Fei M; Adams A; Brodersen LE; Logan BR; Ahn KW; Shaw BE; Kletzel M; Olszewski M
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Biol Blood Marrow Transplant Volume: 24 Page(s): 1313 - 1321
07/01/2018 Authors: Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
Biol Blood Marrow Transplant Volume: 24 Page(s): 1216 - 1222
06/01/2018 Authors: Shenoy S; Walters MC; Ngwube A; Soni S; Jacobsohn D; Chaudhury S; Grimley M; Chan K; Haight A; Kasow KA
Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives.
Biol Blood Marrow Transplant Volume: 24 Page(s): 1041 - 1048
05/01/2018 Authors: Khemani K; Ross D; Sinha C; Haight A; Bakshi N; Krishnamurti L
Abatacept for GVHD Prophylaxis after Hematopoietic Stem Cell Transplantation (HCT) for Pediatric Sickle Cell Disease (SCD): A Sickle Transplant Alliance for Research (STAR) Trial
Volume: 24 Page(s): S86 - S86
03/01/2018 Authors: Chaudhury S; Laskowski J; Rangarajan HG; Abraham A; Haight AE; Guilcher GMT; Sosna J; Robinson C; Horan J; Bhatia M
Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation
Volume: 130
12/07/2017 Authors: Stenger E; Khemani K; Ross D; Meacham L; McCracken C; Haight A; Krishnamurti L
A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for -Thalassemia.
Biol Blood Marrow Transplant Volume: 23 Page(s): 1695 - 1700
10/01/2017 Authors: Chaudhury S; Ayas M; Rosen C; Ma M; Viqaruddin M; Parikh S; Kharbanda S; Chiang KY; Haight A; Bhatia M
Genotype, Phenotype and T Cell Counts at One Year Predict Survival and Long Term Immune Reconstitution after Transplantation in Severe Combined Immune Deficiency (SCID)-The Primary Immune Deficiency Treatment Consortium (PIDTC)
Volume: 23 Page(s): S101 - S102
03/01/2017 Authors: Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Puck J; Prockop SE; Kapoor N; Abdel-Azim H
African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation.
Biol Blood Marrow Transplant Volume: 23 Page(s): 357 - 360
02/01/2017 Authors: Sano H; Hilinski JA; Applegate K; Chiang K-Y; Haight A; Qayed M; Horan J
Family Strategies to Support Siblings of Pediatric Hematopoietic Stem Cell Transplant Patients.
Pediatrics Volume: 139
02/01/2017 Authors: White TE; Hendershot KA; Dixon MD; Pelletier W; Haight A; Stegenga K; Alderfer MA; Cox L; Switchenko JM; Hinds P
CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation
Volume: 128
12/02/2016 Authors: Sano H; Hilinski J; Applegate K; Camacho-Gonzalez A; Chandrakasan S; Chiang K-Y; Haight A; Krishnamurti L; Stenger E; Qayed M
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.
Blood Volume: 128 Page(s): 2561 - 2567
11/24/2016 Authors: Shenoy S; Eapen M; Panepinto JA; Logan BR; Wu J; Abraham A; Brochstein J; Chaudhury S; Godder K; Haight AE
Recipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia: A Case Report.
J Pediatr Hematol Oncol Volume: 38 Page(s): e310 - e314
11/01/2016 Authors: Carden MA; Caltharp S; Yee ME; Haight AE; Westblade LF; Park S
Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.
Volume: 63 Page(s): 908 - 913
05/01/2016 Authors: Nickel RS; Seashore E; Lane PA; Alazraki AL; Horan JT; Bhatia M; Haight AE
Unrelated Donor Marrow (BMT) or Cord Blood Transplantation (UCBT) for Thalassemia Major after Reduced Intensity Conditioning (URTH Trial Extension)
Volume: 22 Page(s): S356 - S356
03/01/2016 Authors: Shenoy S; Ngwube A; Walters MC; Abraham A; Chaudhury S; Soni S; Pulsipher MA; Chan KW; Nieder ML; Parikh S
Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
Int J Radiat Oncol Biol Phys Volume: 94 Page(s): 349 - 359
02/01/2016 Authors: Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang K-Y; Butker E; Khan MK; Haight AE; Chen Z
Factors Influencing Non-Infectious Interstitial Pneumonia in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation Based Myeloablative Conditioning
Volume: 93 Page(s): S194 - S194
11/01/2015 Authors: Abugideiri M; Nanda RH; Butker C; Chiang K-Y; Butker E; Khan MK; Kim S; Chen Z; Haight AE; Esiashvili N
Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
Biol Blood Marrow Transplant Volume: 21 Page(s): 1845 - 1852
10/01/2015 Authors: Stenger EO; Chiang K-Y; Haight A; Qayed M; Kean L; Horan J
The effects of hydroxyurea and bone marrow transplant on Anti-Mllerian hormone (AMH) levels in females with sickle cell anemia.
Blood Cells Mol Dis Volume: 55 Page(s): 56 - 61
06/01/2015 Authors: Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trial.
Biol Blood Marrow Transplant Volume: 21 Page(s): 900 - 905
05/01/2015 Authors: Horan JT; Haight A; Dioguardi JL; Brown C; Grizzle A; Shelman C; Kanter J; Hale G; Nieder M; Benton M
The ethics of a proposed study of hematopoietic stem cell transplant for children with "less severe" sickle cell disease.
Blood Volume: 124 Page(s): 861 - 866
08/07/2014 Authors: Nickel RS; Hendrickson JE; Haight AE
Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
N Engl J Med Volume: 371 Page(s): 434 - 446
07/31/2014 Authors: Pai S-Y; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich AH; Jyonouchi S
Unmet needs of siblings of pediatric stem cell transplant recipients.
Pediatrics Volume: 133 Page(s): e1156 - e1162
05/01/2014 Authors: Pentz RD; Alderfer MA; Pelletier W; Stegenga K; Haight AE; Hendershot KA; Dixon M; Fairclough D; Hinds P
Randomized clinical trial of therapeutic music video intervention for resilience outcomes in adolescents/young adults undergoing hematopoietic stem cell transplant: a report from the Children's Oncology Group.
Cancer Volume: 120 Page(s): 909 - 917
03/15/2014 Authors: Robb SL; Burns DS; Stegenga KA; Haut PR; Monahan PO; Meza J; Stump TE; Cherven BO; Docherty SL; Hendricks-Ferguson VL
Retrospective Study of 240 Patients with Severe Combined Immunodeficiency Transplanted from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America
Volume: 20 Page(s): S24 - S25
02/01/2014 Authors: Pai S-Y; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich A; Jyonouchi S
Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major A er a Reduced Intensity Conditioning Regimen (URTH Trial)
Volume: 122
11/15/2013 Authors: Shenoy S; Murray L; Walters MC; Chaudhury S; Soni S; Pulsipher MA; Schultz KR; Chan K; Nieder M; Loechelt B
Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.
J Pediatr Hematol Oncol Volume: 35 Page(s): 289 - 298
05/01/2013 Authors: Omondi NA; Ferguson SES; Majhail NS; Denzen EM; Buchanan GR; Haight AE; Labotka RJ; Rizzo JD; Murphy EA
Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant.
Pediatr Crit Care Med Volume: 14 Page(s): 261 - 267
03/01/2013 Authors: Duncan CN; Lehmann LE; Cheifetz IM; Greathouse K; Haight AE; Hall MW; Herschberger A; Hill KS; Moffet JR; Morrison RR
Pneumatosis intestinalis in pediatric hematopoietic stem cell transplantation patients: an uncommon complication.
Fetal Pediatr Pathol Volume: 31 Page(s): 309 - 314
10/01/2012 Authors: Shulman SC; Chiang F; Haight AE; Steelman CK; Chiang K-Y; Gow K; Shehata BM
Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma.
Pediatr Blood Cancer Volume: 58 Page(s): 448 - 452
03/01/2012 Authors: Qayed M; Chiang K-Y; Ricketts R; Alazraki A; Tahvildari A; Haight A; George B; Esiashvili N; Katzenstein HM
TARGETING MEMORY T CELLS WITH ALEFACEPT TO ABROGATE TRANSFUSION ALLOIMMUNIZATION: PRELIMINARY RESULTS FROM A TRIAL OF REDUCED INTENSITY CONDITIONING AND ALLOGENEIC TRANSPLANT FOR CHILDREN WITH NON-MALIGNANT HEMATOLOGIC DISEASES
Volume: 18 Page(s): S325 - S325
02/01/2012 Authors: Horan JT; Qayed M; Haight A; Couture C; Chiang KY; Kean L
BI-MODAL AGE DISTRIBUTION OF PATIENTS WITH RELAPSED HODGKIN LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION CORRELATES WITH MARKEDLY INFERIOR SURVIVAL AMONG PATIENTS AGE 35 YEARS AND OLDER
Volume: 18 Page(s): S296 - S296
02/01/2012 Authors: Sharma A; Duan M; Chowdhury R; Graiser M; Zhang H; Langston A; Lonial S; Flowers CR; Haight A; Waller EK
Red Blood Cell (RBC) Transfusion Requirements During Matched Sibling Donor Bone Marrow Transplantation for Sickle Cell Disease Are Lower in Patients Who Receive Extended RBC Phenotype Matching
Volume: 51 Page(s): 113A - 113A
09/01/2011 Authors: McPherson M; Haight AE; Jessup P; Castillejo M; Josephson C
LOWER OVERALL SURVIVAL IN AFRICAN AMERICAN PATIENTS UNDERGOING UNRELATED UMBILICAL CORD BLOOD TRANSPLANT: RESULTS OF A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 903 - 904
06/01/2011 Authors: Pauly M; Andrews J; Applegate K; Chiang K-Y; Couture C; Haight A; Li R; Kean L; Qayed M; Horan J
RE-IMMUNIZATION PRACTICES AMONG SURVIVORS OF PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT
Volume: 17 Page(s): S276 - S276
02/01/2011 Authors: Keeley NE; Cherven BO; Weinzierl E; Olson E; Thompson A; Mertens A; Haight AE
Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.
Bone Marrow Transplant Volume: 46 Page(s): 27 - 33
01/01/2011 Authors: McPherson ME; Hutcherson D; Olson E; Haight AE; Horan J; Chiang K-Y
Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
Biol Blood Marrow Transplant Volume: 16 Page(s): 1212 - 1221
09/01/2010 Authors: Pulsipher MA; Horwitz EM; Haight AE; Kadota R; Chen AR; Frangoul H; Cooper LJN; Jacobsohn DA; Goyal RK; Mitchell D
Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?
Pediatr Blood Cancer Volume: 55 Page(s): 199 - 201
07/15/2010 Authors: Qayed M; Thompson A; Applegate K; Haight A; Rogatko A; Chiang K-Y; Horan J
Tandem stem cell transplantation as consolidation therapy for high-risk neuroblastoma: The Children's Healthcare of Atlanta experience
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Qayed M; Chiang KY; Haight AE; George BA; Ricketts R; Alazraki A; Tahvildari A; Esiashvili N; Katzenstein HM
Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease (vol 16, pg 263, 2009)
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Volume: 16 Page(s): 562 - 562
04/01/2010 Authors: Walters; Haight A
THE UPDATED SCHWARTZ FORMULA AS A SCREENING TEST FOR ABNORMAL KIDNEY FUNCTION PRIOR TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
Volume: 16 Page(s): S261 - S261
02/01/2010 Authors: Qayed M; Thompson A; Applegate K; Haight A; Chiang K-Y; Horan J
Successful use of extracorporeal life support in a hematopoietic stem cell transplant patient with diffuse alveolar hemorrhage.
Pediatr Crit Care Med Volume: 11 Page(s): e4 - e7
01/01/2010 Authors: Morris SH; Haight AE; Kamat P; Fortenberry JD
Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
Transfusion Volume: 49 Page(s): 1977 - 1986
09/01/2009 Authors: McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo M-I; Hillyer CD; Josephson CD
Racial/ethnic diversity in children's oncology clinical trials: ten years later.
Cancer Volume: 115 Page(s): 3808 - 3816
08/15/2009 Authors: Lund MJ; Eliason MT; Haight AE; Ward KC; Young JL; Pentz RD
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.
Blood Volume: 114 Page(s): 1429 - 1436
08/13/2009 Authors: Pulsipher MA; Boucher KM; Wall D; Frangoul H; Duval M; Goyal RK; Shaw PJ; Haight AE; Grimley M; Grupp SA
Relationship of Targeted Busulfan Exposure to Engraftment in Children Undergoing Myeloablative Matched Sibling Donor Transplantation for Sickle Cell Disease
Volume: 112 Page(s): 749 - 750
11/16/2008 Authors: McPherson ME; Hutcherson D; Olson E; Haight A; Horan J; Chiang K-Y
Transfusion management of HLA-matched sibling donor bone marrow transplant (MSD-BMT) recipients with sickle cell disease (SCD)
Volume: 48 Page(s): 256A - 256A
09/01/2008 Authors: McPherson M; Anderson A; Haight A; Hillyer C; Jessup P; Castillejo M-I; Josephson C
CD36 immunization in a patient undergoing hematopoietic stem cell transplantation.
Pediatr Blood Cancer Volume: 50 Page(s): 660 - 662
03/01/2008 Authors: Culler EE; Hillyer CD; Haight AE; Castillejo M-I; Josephson CD
METHOTREXATE AND PIPERACILLIN/TAZOBACTAM VERSUS METHOTREXATE AND CEFTAZIDIME: A LOOK AT TIME TO ENGRAFTMENT AND SIDE EFFECT PROFILE DIFFERENCES IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
Volume: 14 Page(s): 165 - 165
02/01/2008 Authors: Hoffmann PD; Haight AE
The ethical justification for minor sibling bone marrow donation: a case study.
Oncologist Volume: 13 Page(s): 148 - 151
02/01/2008 Authors: Pentz RD; Haight AE; Noll RB; Barfield R; Pelletier W; Davies S; Alderfer MA; Hinds PS
Successful engraftment using varied stem cell sources, low toxicity, and long-term survival using a Bu/Flu/ATG, reduced intensity allogeneic transplantation in high risk pediatric patients ineligible for myelablative therapy: Results of the pediatric blood and marrow transplant consortium (PBMTC) study ONC0313
Volume: 110 Page(s): 192A - 193A
11/16/2007 Authors: Pulsipher MA; Frangoul H; Duval M; Goyal R; Shaw PJ; Haight A; Kadota R; Grimley M; Grupp SA; Kletzel M
Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.
Pediatr Transplant Volume: 11 Page(s): 641 - 644
09/01/2007 Authors: Adamkiewicz TV; Szabolcs P; Haight A; Baker KS; Staba S; Kedar A; Chiang KY; Krishnamurti L; Boyer MW; Kurtzberg J
Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.
Pediatr Transplant Volume: 11 Page(s): 279 - 285
05/01/2007 Authors: Chiang K-Y; Haight A; Horan J; Olson E; Gartner A; Hartman D; Youssef S; Worthington-White D
Low rates of toxicity and long-term responses after BU/FLU/ATG RIC allogeneic transplantation in very high risk pediatric patients ineligible for myelablative therapy: A pediatric blood and marrow transplant consortium study
Volume: 13 Page(s): 29 - 30
02/01/2007 Authors: Pinsipher MA; Goyal R; Frangoul H; Shaw P; Haight A; Kadota R; Wall D; Gropp S; Kletzel M
Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
Br J Haematol Volume: 136 Page(s): 673 - 676
02/01/2007 Authors: Eggleston B; Patience M; Edwards S; Adamkiewicz T; Buchanan GR; Davies SC; Dickerhoff R; Donfield S; Feig SA; Giller RH
Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experience.
J Pediatr Surg Volume: 41 Page(s): 662 - 667
04/01/2006 Authors: Gow KW; Wulkan ML; Heiss KF; Haight AE; Heard ML; Rycus P; Fortenberry JD
Pharmacokinetics of anti tumor necrosis factor antibody (infliximab) in children with acute GVHD involving the gastrointestinal
Volume: 12 Page(s): 69 - 69
02/01/2006 Authors: Sleight B; Shenoy S; Haight A; Vora R; Prabhakar U; Schultz K; Gamis A; Levine J; Braun T; Yanik G
Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease.
J Pediatr Hematol Oncol Volume: 28 Page(s): 29 - 32
01/01/2006 Authors: Adamkiewicz TV; Boyer MW; Bray R; Haight A; Yeager AM
Unrelated cord blood transplantation (UCBT) in children with sickle cell disease (SCD): US centers experience.
Volume: 106 Page(s): 578A - 578A
11/16/2005 Authors: Adamkiewicz TV; Haight A; Mazur MA; Baker KS; Szabolcs P; Kedar A; Chiang KY; Krishnamurti L; Wagner JE; Wingard JR
Single institution experience with HHV6 infections in the pediatric HSCT patients
Volume: 10 Page(s): 41 - 41
02/01/2004 Authors: Olson EA; Chiang KY; Haight AE; Bowman L
A decade of myeloablatiye HLA-matched sibling marrow transplantation for children with severe sickle cell disease: Outcomes and lessons learned from the Atlanta experience
Volume: 10 Page(s): 29 - 29
02/01/2004 Authors: Haight AE; Rudolph CA; Eckman JR; Hsu LL; Bowman LC; Chiang KY; Olson E; Lauer M; Yeager AM; Adamkiewicz T
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma.
Blood Volume: 101 Page(s): 1718 - 1726
03/01/2003 Authors: Rousseau RF; Haight AE; Hirschmann-Jax C; Yvon ES; Rill DR; Mei Z; Smith SC; Inman S; Cooper K; Alcoser P
Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation.
Radiology Volume: 226 Page(s): 399 - 404
02/01/2003 Authors: Haight AE; Kaste SC; Goloubeva OG; Xiong XP; Bowman LC
Occult orbital neuroblastoma detected after administration of an antitumor vaccine.
Ophthalmic Plast Reconstr Surg Volume: 19 Page(s): 77 - 79
01/01/2003 Authors: Wilson MW; Moshfeghi DM; Haik BG; Haight AE; Hill DA; Davidoff AM; Rousseau RF; Bowman LC
Humoral response to vaccination with interleukin-2-expressing allogeneic neuroblastoma cells after primary therapy.
Med Pediatr Oncol Volume: 35 Page(s): 712 - 715
12/01/2000 Authors: Haight AE; Bowman LC; Ng CY; Vanin EF; Davidoff AM
Immunotherapy with IL-2 expressing allogeneic tumor cells after primary therapy for high-risk neuroblastoma: Clinical outcomes and generation of both cellular and humoral immune responses.
BLOOD Volume: 96 Page(s): 801A - 801A
11/16/2000 Authors: Haight AE; Davidoff AM; Ng CYC; Vanin EF; Bowman LC
Outcomes of 44 pediatric MDS and JMML patients treated with allogeneic BMT: Support for early transplantation.
Volume: 96 Page(s): 415A - 415A
11/16/2000 Authors: Haight AE; Woodard P; Srivastava DK; Raimondi SC; Behm FG; Ribeiro RC; Cunningham JM; Benaim E; Horwitz EM; Hale GA
Budd-Chiari syndrome caused by Gaucher's disease.
Pediatr Radiol Volume: 29 Page(s): 908 - 910
12/01/1999 Authors: Haliloglu M; Hoffer FA; Haight AE; Cunningham JM

Directory section navigation

Profile

Ann Haight MD

Academic Appointment

Education

Degrees

Research

Focus

Publications